FAT/CD36 expression is not ablated in spontaneously hypertensive rats

Journal of Lipid Research

Volumn 50, Issue 4, 2009, Pages 740-748

  Bonen, Arend ^a   Han, Xiao Xia ^a   Tandon, Narendra N ^b   Glatz, Jan F C ^c   Lally, James ^a   Snook, Laelie A ^a   Luiken, Joost J F P ^c  

^a UNIVERSITY OF GUELPH   (Canada)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Fatty acid transport; Glucose transport; Heart; Liver adipose; Muscle; Tissue

Indexed keywords

CD36 ANTIGEN; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; MESSENGER RNA; CD36 PROTEIN, RAT; FATTY ACID; GLUCOSE; PALMITIC ACID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FATTY ACID TRANSPORT; GENE EXPRESSION; GENE MUTATION; GLUCOSE TRANSPORT; HEART; HYPERTENSION; INSULIN RESISTANCE; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE DISTRIBUTION; UPREGULATION; ACTIVE TRANSPORT; ANIMAL; GENETICS; HEART MUSCLE; MALE; METABOLISM; PHYSIOLOGY; WISTAR KYOTO RAT;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE; FATTY ACIDS; GENE EXPRESSION; GLUCOSE; HYPERTENSION; INSULIN RESISTANCE; LIVER; MALE; MUSCLE, SKELETAL; MYOCARDIUM; PALMITIC ACID; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 67449164714     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800237-JLR200     Document Type: Article

References (54)

1. Bonen, A., A. Chabowski, J. J. F. P. Luiken, and J. F. C. Glatz. 2007. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda). 22: 15-29.
2. Kampf, J. P., and A. M. Kleinfeld. 2007. Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane. Physiology (Bethesda). 22: 7-14.
3. Kampf, J. P., A. M. Kleinfeld, A. Bonen, A. Chabowski, J. J. F. P. Luiken, and J. F. C. Glatz. 2007. Is membrane transport of FFA mediated by lipid, protein, or both?: Points of agreement. Physiology (Bethesda). 22: 29.
4. Stahl, A. 2004. A current review of fatty acid transport proteins (SLC27). Pflugers Arch. 447: 722-727.
5. Febbraio, M., N. A. Abumrad, D. P. Hajjar, K. Sharma, W. Cheng, S. Frieda, A. Pearce, and R. L. Silverstein. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274: 19055-19062.
6. Coburn, C. T., F. F. Knapp, Jr., M. Febbraio, A. L. Beets, R. L. Silverstein, and N. A. Abumrad. 2000. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissue of CD36 knockout mice. J. Biol. Chem. 275: 32523-32529.
7. Bonen, A., X-X. Han, D. D. J. Habets, M. Febbraio, J. F. C. Glatz, and J. J. F. P. Luiken. 2007. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin-, and AICAR-stimulated fatty acid metabolism. Am. J. Physiol. Endocrinol. Metab. 292: E1740-E1749.
8. Habets, D. D., W. A. Coumans, P. J. Voshol, M. A. den Boer, M. Febbraio, A. Bonen, J. F. Glatz, and J. J. Luiken. 2007. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem. Biophys. Res. Commun. 355: 204-210.
9. Kuang, M., M. Febbraio, C. Wagg, G. D. Lopaschuk, and J. R. Dyck. 2004. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation. 109: 1550-1557.
10. Bonen, A., J. J. Luiken, S. Lui, D. J. Dyck, B. Kiens, S. Kristiansen, L. Turcotte, G. J. van der Vusse, and J. F. Glatz. 1998. Palmitate transport and fatty acid transporters in red and white muscles. Am. J. Physiol. Endocrinol. Metab. 275: E471-E478.
11. Luiken, J. J. F. P., L. P. Turcotte, and A. Bonen. 1999. Proteinmediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J. Lipid Res. 40: 1007-1016.
12. Bonen, A., D. J. Dyck, A. Ibrahimi, and N. A. Abumrad. 1999. Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am. J. Physiol. 276: E642-E649.
13. Ibrahimi, A., A. Bonen, W. D. Blinn, T. Hajri, X. Li, K. Zhong, R. Cameron, and N. A. Abumrad. 1999. Muscle-specific overexpression of FAT/ CD36 enhances fatty acid oxidation by contracting muscles, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem. 274: 26761-26766.
14. Koonen, D., C. R. Benton, Y. Arumugam, N. N. Tandon, J. Calles-Escandon, J. F. Glatz, J. J. Luiken, and A. Bonen. 2004. Different mechanism can alter fatty acid transport when muscle contractile activity is chronically altered. Am. J. Physiol. Endocrinol. Metab. 286: 1042-1049.
15. Goudriaan, J. R., V. E. Dahlmans, B. Teusink, D. M. Ouwens, M. Febbraio, J. A. Maassen, J. A. Romijn, L. M. Havekes, and P. J. Voshol. 2003. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J. Lipid Res. 44: 2270-2277.
16. Luiken, J. J. F. P., Y. Arumugam, D. J. Dyck, R. C. Bell, M. L. Pelsers, L. P. Turcotte, N. N. Tandon, J. F. C. Glatz, and A. Bonen. 2001. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J. Biol. Chem. 276: 40567-40573.
17. Coort, S. L. M., D. M. Hasselbaink, D. Y. P. Koonen, J. Willems, W. A. Coumans, A. Chabowski, G. J. van der Vusse, A. Bonen, J. F. C. Glatz, and J. J. F. P. Luiken. 2004. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats. Diabetes. 53: 1655-1663.
18. Han, X. X., A. Chabowski, N. N. Tandon, J. Calles-Escandon, J. F. Glatz, J. J. Luiken, and A. Bonen. 2007. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle. Am. J. Physiol. Endocrinol. Metab. 293: E566-E575.
19. Chabowski, A., J. C. Chatham, N. N. Tandon, J. Calles-Escandon, J. F. C. Glatz, J. J. F. P. Luiken, and A. Bonen. 2006. Fatty acid transport and FAT/CD36 are increased in red but not in white muscle skeletal muscle of Zucker diabetic fatty (ZDF) rats. Am. J. Physiol. Endocrinol. Metab. 291: E675-E682.
20. Bonen, A., M. L. Parolin, G. R. Steinberg, J. Calles-Escandon, N. N. Tandon, J. F. C. Glatz, J. J. F. P. Luiken, G. J. F. Heigenhauser, and D. J. Dyck. 2004. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18: 1144-1146.
21. James, D. J., F. Cairns, I. P. Salt, G. J. Murphy, A. F. Dominiczak, J. M. Connell, and G. W. Gould. 2001. Skeletal muscle of stroke-prone spontaneously hypertensive rats exhibits reduced insulin-stimulated glucose transport and elevated levels of caveolin and flotillin. Diabetes. 50: 2148-2156.
22. Zecchin, H. G., R. M. Bezerra, J. B. Carvalheira, M. A. Carvalho-Filho, K. Metze, K. G. Franchini, and M. J. Saad. 2003. Insulin signalling pathways in aorta and muscle from two animal models of insulin resistance-the obese middle-aged and the spontaneously hypertensive rats. Diabetologia. 46: 479-491.
23. Aitman, T. J., A. M. Glazier, C. A. Wallace, L. D. Cooper, P. J. Norsworthy, F. N. Wahid, K. M. Al-Majali, P. M. Trembling, C. J. Mann, C. C. Shoulders, et al. 1999. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21: 76-83.
24. Hajri, T., A. Ibrahimi, C. T. Coburn, F. F. Knapp, Jr., T. Kurtz, M. Pravenec, and N. A. Abumrad. 2001. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J. Biol. Chem. 276: 23661-23666.
25. Pravenec, M., V. Landa, V. Zidek, M. Musilova, V. Kren, L. Kazdova, T. J. Aitman, A. Glazier, A. Ibrahimi, N. A. Abumrad, et al. 2001. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat. Genet. 27: 156-158.
26. Qi, N., L. Kazdova, V. Zidek, V. Landa, V. Kren, H. A. Pershadsingh, E. S. Lezin, N. A. Abumrad, M. Pravenec, and T. W. Kurtz. 2002. Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone. J. Biol. Chem. 277: 48501-48507.
27. Pravenec, M., V. Landa, V. Zidek, A. Musilova, L. Kazdova, N. Qi, of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol. Res. 52: 681-688.
28. Hajri, T., X. X. Han, A. Bonen, and N. A. Abumrad. 2002. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J. Clin. Invest. 109: 1381-1389.
29. Gotoda, T., Y. Lituzaki, N. Kato, J. Osuga, M-T. Bihoreau, T. Murakami, Y. Yamori, H. Shimano, S. Ishibashi, and N. Ymada. 1999. Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance. Nat. Genet. 22: 226-228.
30. Collison, M., A. M.Glazier, D. Graham, J. J.Morton, M. H. Dominiczak, T. J. Aitman, J. M. Connell, G.W. Gould, and A. F. Dominiczak. 2000. Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes. 49: 2222-2226.
31. Abumrad, N. A., M. R. El-Maghrabi, E-Z. Amri, E. Lopez, and P. Grimaldi. 1993. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268: 17665-17668.
32. Schaffer, J. E., and H. F. Lodish. 1994. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 79: 427-436.
33. Mattingly, J. R., Jr., F. J. Rodriguez-Berrocal, J. Gordon, A. Iriarte, and M. Martinez-Carrion. 1987. Molecular cloning and in vivo expression of a precursor to rat mitochondrial aspartate aminotransferase. Biochem. Biophys. Res. Commun. 149: 859-865.
34. Matsuno, K., M. Diaz-Ricard, R. R. Montgomery, T. Aster, G. A. Jamieson, and N. N. Tandon. 1996. Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br. J. Haematol. 92: 960-967.
35. Bonen, A., J. J. F. P. Luiken, Y. Arumugam, J. F. C. Glatz, and N. N. Tandon. 2000. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 275: 14501-14508.
36. Bonen, A., D. J. Dyck, and J. J. F. P. Luiken. 1998. Skeletal muscle fatty acid transport and transporters. Adv. Exp. Med. Biol. 441: 193-205.
37. Koonen, D. P. Y., W. A. Coumans, Y. Arumugam, A. Bonen, J. F. C. Glatz, and J. J. F. P. Luiken. 2002. Giant membrane vesicles as a model to study cellular substrate uptake dissected from metabolism. Mol. Cell. Biochem. 239: 121-130.
38. Bonen, A., D. Miskovic, and B. Kiens. 1999. Fatty acid transporters (FABPpm, FAT, FATP) in human muscle. Can. J. Appl. Physiol. 24: 515-523.
39. Luiken, J. J., Y. Arumugam, R. C. Bell, J. Calles-Escandon, N. N. Tandon, J. F. Glatz, and A. Bonen. 2002. Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am. J. Physiol. Endocrinol. Metab. 282: 612-621.
40. Chirgwin, J., A. Przbyla, R. MacDonald, and W. Rutter. 1979. Isolation of biologically active ribonucleotic acid from source enriched in ribonuclease. Biochemistry. 18: 5294-5299.
41. Sambrook, J., E. F. Fritisch, and T. Maniatis. Molecular cloning: A laboratory manual, Cold Spring Harbour Laboratory, Cold Spring Harbour NY, 1989.
42. Han, X. X., and A. Bonen. 1998. Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am. J. Physiol. 274: E700-E707.
43. Lemieux, K., X-X. Han, L. Dombrowski, A. Bonen, and A. Marette. 2000. The transferrin receptor defines two distinct contraction-responsive GLUT4 vesicle populations. Diabetes. 49: 183-189.
44. Han, X-X., P. Fernando, and A. Bonen. 2000. Denervation provokes greater reductions in insulin-stimulated glucose transport in muscle than severe diabetes. Mol. Cell. Biochem. 210: 81-89.
45. Luiken, J. J. F. P., D. J. Dyck, X-X. Han, N. N. Tandon, Y. Arumugam, J. F. C. Glatz, and A. Bonen. 2002. Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. Am. J. Physiol. Endocrinol. Metab. 282: E491-E495.
46. Benton, C. R., J. Nickerson, J. Lally, X-X. Han, G. P. Holloway, J. F. C. Glatz, J. J. F. P. Luiken, T. E. Graham, J. J. Heikkila, and A. Bonen. 2008. Modest PGC-1a overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in SS, not IMF, mitochondria. J. Biol. Chem. 283: 4228-4240.
47. Nickerson, J., and A. Bonen. 2005. Defining a role for skeletal muscle fatty acid transport proteins. In 2nd Northern Lights Conference. Canadian Federation of Biological Societies. Guelph, Ontario, Canada. F47.
48. DiRusso, C. C., H. Li, D. Darwis, P. A. Watkins, J. Berger, and P. N. Black. 2005. Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast. J. Biol. Chem. 280: 16829-16837.
49. Clarke, D. C., D. Miskovic, X-X. Han, J. Calles-Escandon, J. F. C. Glatz, J. J. F. P. Luiken, J. J. Heikkila, and A. Bonen. 2004. Overexpression of membrane associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol. Genomics. 17: 31-37.
50. Holloway, G. P., J. Lally, J. G. Nickerson, H. Alkhateeb, L. A. Snook, G. J. Heigenhauser, J. Calles-Escandon, J. F. Glatz, J. J. Luiken, L. L. Spriet, et al. 2007. Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle. J. Physiol. 582: 393-405.
51. Chabowski, A., S. L. M. Coort, J. Calles-Escandon, N. N. Tandon, J. F. C. Glatz, J. J. F. P. Luiken, and A. Bonen. 2005. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett. 579: 2428-2432.
52. Gimeno, R. E., A. M. Ortegon, S. Patel, S. Punreddy, P. Ge, Y. Sun, H. F. Lodish, and A. Stahl. 2003. Characterization of a heart-specific fatty acid transport protein. J. Biol. Chem. 278: 16039-16044.
53. Miyaoka, K., T. Kuwasako, K. Hirano, S. Nozaki, S. Yamashita, and Y. Matsuzawa. 2001. CD36 deficiency associated with insulin resistance. Lancet. 357: 686-687.
54. Smith, A. C., K. L. Mullen, K. A. Junkin, J. Nickerson, A. Chabowski, A. Bonen, and D. J. Dyck. 2007. Metformin and exercise reduce muscle FAT/ CD36 and lipid accumulation and blunt the progression of high-fat diet induced hyperglycemia. Am. J. Physiol. Endocrinol. Metab. 293: E172-E181.